Health Care & Life Sciences » Pharmaceuticals | Daehan New Pharm Co. Ltd.

Daehan New Pharm Co. Ltd. | Mutual Funds

Mutual Funds that own Daehan New Pharm Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DFA Emerging Markets Core Equity Portfolio
112,554
0.78%
0
0.01%
04/30/2018
DFA Emerging Markets Small Cap Series
79,981
0.56%
0
0.01%
01/31/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
2,669
0.02%
0
0%
12/31/2017
DFA TA World (ex-US) Core Equity Portfolio
2,481
0.02%
0
0%
04/30/2018
John Hancock II - Emerging Markets Fund
1,865
0.01%
0
0%
04/30/2018
DFA World (ex-US) Core Equity Portfolio
1,458
0.01%
0
0%
04/30/2018
1,210
0.01%
1,210
0.17%
07/06/2018
341
0%
341
0.13%
01/31/2017

About Daehan New Pharm Co.

View Profile
Address
66 Jeyakgongdan 1-gil
Hwaseong-si GY 18622
Korea, Republic Of
Employees -
Website http://www.dhnp.co.kr
Updated 09/14/2018
Daehan New Pharm Co., Ltd. engages in the production of pharmaceuticals and animal health goods. It operates through the pharmaceutical and animal health product business divisions. The pharmaceutical division provides analgesics anti-inflammatory drugs and antipyretics, antibacterial, antidiabetics, antihistamines, antineoplastics and immunosuppressants, cardiovascular drugs, gatrointestinal drugs, muscle relaxants, antispasmodics, cream or ointments and others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.